Description:

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021); ODM derived from: https://clinicaltrials.gov/show/NCT00087516

Link:

https://clinicaltrials.gov/show/NCT00087516

Keywords:
Versions (2) ▾
  1. 8/30/16
  2. 9/20/21
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type 2 NCT00087516

Eligibility Diabetes Mellitus, Type 2 NCT00087516

Inclusion Criteria
patients with type 2 diabetes mellitus
patient is not pregnant or breastfeeding
male or female patient unlikely to conceive
patient not on an antihyperglycemic drug
Exclusion Criteria
patient has history of type 1 diabetes mellitus
patient has history of ketoacidosis
patient requires insulin within 8 weeks prior to start of study
patient on weight loss program and is not in maintenance phase
patient taking weight loss medication within 8 weeks prior to start of study
patient on or likely to require = 14 days or repeated courses of corticosteroids
patient taking immunosuppressive/immunomodulating medication
patient taking digoxin or other cardiac medication
patient has undergone surgical general anesthesia within 30 days prior to start of study
patient taking investigational drug within 8 weeks prior to start of study
patient is diagnosed with liver disease
patient has chronic myopathy, progressive neurological/neuromuscular disorder
patient has with severe cardiac conditions within the last 6 months
patient is human immunodeficiency virus (hiv) positive
patient has hematological disorder
patient has history of malignancy
patient has history of alcohol or drug abuse within the past 3 years

Similar models